Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
This Phase I clinical study is a randomized, double-blind, placebo-controlled,
parallel-design study to thoroughly assess the safety profile and PK properties of J147 in
healthy subjects. The study will include single ascending dose (SAD) in healthy young and
elderly subjects.